Cargando…

Mixed Hepatocellular Cholangiocarcinoma: A Comparison of Survival between Mixed Tumors, Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma from a Single Center

SIMPLE SUMMARY: Mixed hepatocellular cholangiocarcinoma (mHC-CC) is a very rare tumor and data on its outcome after resection are scarce. The aim of this retrospective study was to compare recurrence and survival after surgery of mixed tumors with data from patients with pure hepatocellular (HCC) or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Penzkofer, Lea, Gröger, Lisa-Katharina, Hoppe-Lotichius, Maria, Baumgart, Janine, Heinrich, Stefan, Mittler, Jens, Gerber, Tiemo S., Straub, Beate K., Weinmann, Arndt, Bartsch, Fabian, Lang, Hauke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913586/ https://www.ncbi.nlm.nih.gov/pubmed/36765596 http://dx.doi.org/10.3390/cancers15030639

Ejemplares similares

Influence of Lymphangio (L), Vascular (V), and Perineural (Pn) Invasion on Recurrence and Survival of Resected Intrahepatic Cholangiocarcinoma
por: Bartsch, Fabian, et al.
Publicado: (2021)

Intrahepatic cholangiocarcinoma – influence of resection margin and tumor distance to the liver capsule on survival
por: Bartsch, Fabian, et al.
Publicado: (2020)

Resection of intrahepatic cholangiocarcinoma in elderly patients – is it reasonable?
por: Bartsch, Fabian, et al.
Publicado: (2019)

Reduced Lipid Peroxidation Predicts Unfavorable Prognosis in Hepatocellular Carcinoma, but Not Intrahepatic Cholangiocarcinoma
por: Gerber, Tiemo Sven, et al.
Publicado: (2023)

Liver Resection for Intrahepatic Cholangiocarcinoma—Single-Center Experience with 286 Patients Undergoing Surgical Exploration over a Thirteen Year Period
por: Lang, Hauke, et al.
Publicado: (2021)

Relevance of suspicious lymph nodes in preoperative imaging for resectability, recurrence and survival of intrahepatic cholangiocarcinoma
por: Bartsch, Fabian, et al.
Publicado: (2020)

Integrative Analysis of Intrahepatic Cholangiocarcinoma Subtypes for Improved Patient Stratification: Clinical, Pathological, and Radiological Considerations
por: Gerber, Tiemo S., et al.
Publicado: (2022)

N-Cadherin Distinguishes Intrahepatic Cholangiocarcinoma from Liver Metastases of Ductal Adenocarcinoma of the Pancreas
por: Gerber, Tiemo S., et al.
Publicado: (2022)

Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplant
por: Brandão, Ajacio Bandeira de Mello, et al.
Publicado: (2022)

Correction: Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplant
por: Brandão, Ajacio Bandeira de Mello, et al.
Publicado: (2023)

Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Massarweh, Nader N., et al.
Publicado: (2017)

Elderly Patients with Hepatocellular Carcinoma Benefit from Liver Transplantation as Much as Younger Ones
por: Mittler, Jens, et al.
Publicado: (2022)

Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resection
por: Song, Peipei, et al.
Publicado: (2019)

Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma
por: Auer, Timo Alexander, et al.
Publicado: (2023)

Survival Prediction in Intrahepatic Cholangiocarcinoma: A Proof of Concept Study Using Artificial Intelligence for Risk Assessment
por: Müller, Lukas, et al.
Publicado: (2021)

Clinicopathological Significance of Syndecan-1 in Cholangiocarcinoma: A Study Based on Immunohistochemistry and Public Sequencing Data
por: Gerber, Tiemo S., et al.
Publicado: (2021)

Outcome after Resection for Hepatocellular Carcinoma in Noncirrhotic Liver—A Single Centre Study
por: Penzkofer, Lea, et al.
Publicado: (2022)

Geographic Variation of Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma, and Hepatocellular Carcinoma in the United States
por: Altekruse, Sean F., et al.
Publicado: (2015)

MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
por: Sammon, Jennifer, et al.
Publicado: (2018)

Development and Validation of a Nomogram for Differentiating Combined Hepatocellular Cholangiocarcinoma From Intrahepatic Cholangiocarcinoma
por: Wang, Tao, et al.
Publicado: (2020)

Staging and Prognostic Models for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Burkhart, Richard A., et al.
Publicado: (2017)

Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Kis, Bela, et al.
Publicado: (2017)

Proteome Landscapes of Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Yi, Xiao, et al.
Publicado: (2023)

Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma
por: Pomyen, Yotsawat, et al.
Publicado: (2023)

Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma
por: Yang, Jie, et al.
Publicado: (2020)

Molecular Subtypes and Precision Oncology in Intrahepatic Cholangiocarcinoma
por: Czauderna, Carolin, et al.
Publicado: (2021)

Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma
por: Jeong, Seogsong, et al.
Publicado: (2016)

Atypical hemangioma mimicking mixed hepatocellular cholangiocarcinoma: Case report
por: Lin, Shengzhang, et al.
Publicado: (2017)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Venkat, Puja S., et al.
Publicado: (2017)

Classification of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Based on Radiomic Analysis
por: Xu, Xiaoliang, et al.
Publicado: (2022)

Survival After Adrenalectomy for Metastatic Hepatocellular Carcinoma: A 25-year Institutional Experience
por: Staubitz, JI., et al.
Publicado: (2020)

Preoperative Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Nomogram Based on Ultrasonographic Features and Clinical Indicators
por: Chen, Yanling, et al.
Publicado: (2022)

Comprehensive analysis of transcriptome and metabolome analysis in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma
por: Murakami, Yoshiki, et al.
Publicado: (2015)

A novel murine model of combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma
por: Xu, Ru-Chen, et al.
Publicado: (2022)

Differentiation of Hepatocellular Carcinoma from Intrahepatic Cholangiocarcinoma through MRI Radiomics
por: Liu, Ning, et al.
Publicado: (2023)

Survival outcomes of combined hepatocellular‐cholangiocarcinoma compared with intrahepatic cholangiocarcinoma: A SEER population‐based cohort study
por: Yang, Zhen, et al.
Publicado: (2021)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
por: Renzulli, Matteo, et al.
Publicado: (2021)

The Addition of Transarterial Chemoembolization to Palliative Chemotherapy Extends Survival in Intrahepatic Cholangiocarcinoma
por: Gairing, Simon Johannes, et al.
Publicado: (2021)

Surgical therapy of primary hepatic angiosarcoma
por: Tripke, Verena, et al.
Publicado: (2019)

Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular–cholangiocarcinoma
por: Chiu, Tai-Jan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ldhe2v206m0g1v8n63pl7br6lv